Organogenesis
ORGO
#6884
Rank
โ‚น53.18 B
Marketcap
โ‚น419.09
Share price
-1.69%
Change (1 day)
41.42%
Change (1 year)

Revenue for Organogenesis (ORGO)

Revenue in 2025 (TTM): โ‚น40.28 Billion

According to Organogenesis's latest financial reports the company's current revenue (TTM ) is โ‚น41.78 Billion. In 2024 the company made a revenue of โ‚น41.35 Billion an increase over the revenue in the year 2023 that were of โ‚น36.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Organogenesis from 2016 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น40.28 B-2.59%
2024 โ‚น41.35 B14.68%
2023 โ‚น36.05 B-3.36%
2022 โ‚น37.31 B7.1%
2021 โ‚น34.83 B40.81%
2020 โ‚น24.74 B32.94%
2019 โ‚น18.61 B-17.67%
2018 โ‚น22.60 B
2017 N/A
2016 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.32 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.74 B 38.19%๐Ÿ‡บ๐Ÿ‡ธ USA